The collaborative research agreement with Graduate School of Medicine Kyoto University was signed.
To research about a newly gene-mutated pain disease and to develop a novel analgesic drug for it, AlphaNavi Pharma Inc., and Graduate School of Medicine Kyoto University signed the collaborative research agreement. Under this agreement, the department of pain pharmacogenetics, one of collaborative research laboratories, has established.
Please refer to the link as below.
http://www.med.kyoto-u.ac.jp/en/organization-staff/collaboration/#a12